J Bártek
- Oncology top 10%
- Cancer-related Molecular Pathways 2
- Biotechnology top 10%
- Cancer Research and Treatments 1
-
- Cancer Genomics and Diagnostics 1
-
- Glycosylation and Glycoproteins Research 1
- Protein purification and stability 1
-
- Skin and Cellular Biology Research 1
-
- Radiopharmaceutical Chemistry and Applications 1
- Monoclonal and Polyclonal Antibodies Research 1
- Co-authors
- David P. LaneCarol MidgleyBořivoj VojtěšekC. FisherD M BarnesRosalind A. EelesJiřina BártkováD. Averill
- Cited by
- OncologyBiotechnologyCancer Research
- Journals
- Journal of Cell Science (1 paper)PubMed (5 papers)European Journal of Cancer and Clinical Oncology (1 paper)
- Partner nations
- United KingdomRussia
In The Last Decade
J Bártek
7 papers receiving 394 citations
Peers
Comparison fields: 5 of 48
- Oncology 321
- Biotechnology 67
- Cancer Research 81
- Pathology and Forensic Medicine 61
- Dermatology 27
Countries citing papers authored by J Bártek
This map shows the geographic impact of J Bártek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Bártek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Bártek more than expected).
Fields of papers citing papers by J Bártek
This network shows the impact of papers produced by J Bártek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Bártek. The network helps show where J Bártek may publish in the future.
Co-authorship network
The 17 scholars most cited alongside J Bártek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. | 1993 | 46 |
| 2 | The role of TP53 in breast cancer development. | 1993 | 28 |
| 3 | 1992 | 310 | |
| 4 | Phyllogenetically conserved epitopes of the keratin 8 polypeptide recognized by a novel set of monoclonal antibodies. | 1991 | 2 |
| 5 | 1985 | 3 | |
| 6 | Production and characterization of monoclonal antibodies against human transferrin. | 1984 | 16 |
| 7 | The relation of iron uptake to the proliferation of erythroid and hemopoietic cells. | 1983 | 1 |
About J Bártek
J Bártek is a scholar working on Biotechnology, Biomaterials and Oncology, having authored 7 papers that have together received 406 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (2 papers), Glycosylation and Glycoproteins Research (1 paper), Protein purification and stability (1 paper), Skin and Cellular Biology Research (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Cancer Research and Treatments (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (321 citations), Biotechnology (67 citations) and Cancer Research (81 citations). J Bártek has collaborated with scholars based in United Kingdom and Russia. Frequent co-authors include David P. Lane, Carol Midgley, Bořivoj Vojtěšek, C. Fisher, D M Barnes, Rosalind A. Eeles, Jiřina Bártková, D. Averill, William Warren and Petr Dráber. Their work appears in journals such as Journal of Cell Science, PubMed and European Journal of Cancer and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.